Skip to main content
SpringerLink
Log in

Complexation of labile metal ions and effect on toxicity

  • Section 4 Mechanisms of Metal Toxicity
  • Published:
Biological Trace Element Research Aims and scope Submit manuscript

Abstract

Chelating agents that have been or may be employed for the treatment of lead, iron, and aluminum overload conditions are described. Although EDTA has been used successfully for treatment of acute lead poisoning, superior ligands for this purpose can be developed. The use of desferriferrioxamine B (DFB) for the treatment of iron overload has several disadvantages, and superior iron chelators are now available. Aluminum overload may also be treated with DFB, but many superior ligands, including chelators designed for iron, are now available for clinical tests.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. C&En News, Aug. 8, 1988, p. 23/Aug. 15, 1988, p. 5.

  2. J. C. Aub, A. M. Butler, R. K. Byers, H. Foreman, H. E. Harrison, B. Kissin, G. L. Maison, T. L. Shipman, and M. Rubin,Arch. Ind. Hyg. Occuptional Med. 7, 137 (1953).

    Google Scholar 

  3. H. S. Waxman and E. B. Brown,Progress in Hematology, E. Brown and C. V. More, eds., Grune and Stratton, New York, 1975.

    Google Scholar 

  4. W. F. Anderson and M. C. Hiller, Department of Health, Education and Welfare, Publication No. 77-994, Bethesda, MD, 1975.

  5. A. E. Martell, R. J. Motekaitis, I. Murase, L. F. Sala, R. Stoldt, C. Y. Ng, H. Rosenkrantz, and J. J. Metterville,Inorg. Chim. Acta 138, 215 (1987).

    Article  Google Scholar 

  6. C. G. Pitt, G. Gupta, W. E. Estes, H. Rosendrantz, J. J. Metterville, A. L. Crumbliss, R. A. Palmer, K. W. Nordquest, K. A. Sprinkle Hardy, D. R. Witcomb, B. R. Byers, J. E. Arceneaux, C. G. Gaines, and C. V. Sciortino,J. Pharmacol. Exp. Ther. 208, 12 (1979).

    PubMed  CAS  Google Scholar 

  7. K. N. Raymond, V. L. Pecoraro, and F. L. Weitle,Development of Iron Chelators for Clinical Use, A. E. Martell, W. F. Anderson, and D. F. Badman, eds., Elsevier, New York, pp. 103–131, 1981.

    Google Scholar 

  8. H. Rosenkrantz and J. J. Metterville, Final Report to NIH, No. MRI-CA-06-85-13 (1985).

  9. A. E. Martell and R. M. Smith,Critical Stability Constants, vols. 1–6, Plenum, New York, 1974, 1975, 1977, 1976, 1982, 1989.

    Google Scholar 

  10. A. Evers, R. D. Hancock, A. E. Martell, and R. J. Motekaitis,Inorg. Chem., in press.

  11. R. D. Hancock and A. E. Martell,Comm. Inorg. Chem. 6, 237 (1988).

    Article  CAS  Google Scholar 

  12. R. D. Hancock and A. E. Martell,Chem. Revs., submitted.

Download references

Author information

Authors and Affiliations

  1. Department of Chemistry, Texas A&M University, 77843-3255, College Station, TX

    Arthur E. Martell

Authors
  1. Arthur E. Martell
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Martell, A.E. Complexation of labile metal ions and effect on toxicity. Biol Trace Elem Res 21, 295–303 (1989). https://doi.org/10.1007/BF02917267

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02917267

Index Entries

Search

Navigation